First phase of research into bad breath completed
Dunedin-based company Blis Technologies has announced the successful completion of the first phase of a research programme on preventing bad breath in dogs.
The company says the trial of its K12 probiotic on dogs was encouraging enough to commence a longer, extended dosing trial.
That trial started in Dunedin last week.
Blis also recently launched the M18 lozenge in New Zealand.
That launch saw a slight lift in the company's share price.